Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Curran

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Drug Discovery Today. Therapeutic Strategies|September 28, 2011
EMERGING THERAPIES AND NOVEL APPROACHES TO VISCERAL PAINUrsula Wesselmann, Andrew P Baranowski, Mats Börjesson, et al.
JAMA Psychiatry|April 19, 2023
Effect of Brief Interpersonal Therapy on Depression During Pregnancy: A Randomized Clinical TrialBenjamin L Hankin, Catherine H Demers, Ella-Marie P Hennessey, et al.
Scientific Reports|March 9, 2019
Quantifying Tip60 (Kat5) stratifies breast cancerA McGuire, M C Casey, A Shalaby, et al.
BMC Cancer|July 21, 2019
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancerM C Casey, A Prakash, E Holian, et al.
Addiction Science & Clinical Practice|September 11, 2024
Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trialSebastian T Tong, Kris Pui Kwan Ma, Ajla Pleho, et al.
Archives of Dermatological Research|January 29, 2000
Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991R W Baldwin, J A Clegg, A C Curran, et al.
Urologic Oncology|June 24, 2021
An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancerK Montazeri, G Dranitsaris, J D Thomas, et al.
Breast Cancer Research and Treatment|January 21, 2010
Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)F T Martin, R M Dwyer, J Kelly, et al.
Contemporary Clinical Trials|October 9, 2017
Improving the quality of depression and pain care in multiple sclerosis using collaborative care: The MS-care trial protocolDawn M Ehde, Kevin N Alschuler, Mark D Sullivan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparisonG C Toner, J D Shapiro, C R Laidlaw, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Drug Discovery Today. Therapeutic Strategies|September 28, 2011
EMERGING THERAPIES AND NOVEL APPROACHES TO VISCERAL PAINUrsula Wesselmann, Andrew P Baranowski, Mats Börjesson, et al.
JAMA Psychiatry|April 19, 2023
Effect of Brief Interpersonal Therapy on Depression During Pregnancy: A Randomized Clinical TrialBenjamin L Hankin, Catherine H Demers, Ella-Marie P Hennessey, et al.
Scientific Reports|March 9, 2019
Quantifying Tip60 (Kat5) stratifies breast cancerA McGuire, M C Casey, A Shalaby, et al.
BMC Cancer|July 21, 2019
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancerM C Casey, A Prakash, E Holian, et al.
Addiction Science & Clinical Practice|September 11, 2024
Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trialSebastian T Tong, Kris Pui Kwan Ma, Ajla Pleho, et al.
Archives of Dermatological Research|January 29, 2000
Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991R W Baldwin, J A Clegg, A C Curran, et al.
Urologic Oncology|June 24, 2021
An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancerK Montazeri, G Dranitsaris, J D Thomas, et al.
Breast Cancer Research and Treatment|January 21, 2010
Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)F T Martin, R M Dwyer, J Kelly, et al.
Contemporary Clinical Trials|October 9, 2017
Improving the quality of depression and pain care in multiple sclerosis using collaborative care: The MS-care trial protocolDawn M Ehde, Kevin N Alschuler, Mark D Sullivan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparisonG C Toner, J D Shapiro, C R Laidlaw, et al.
Pageof 17